Skip to main content
Figure 4 | Journal of Translational Medicine

Figure 4

From: Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and up-regulated pancreatic NF-kappa B and iNOS expression in monosodium glutamate-induced obese rats: Is that a latent disadvantage?

Figure 4

Fenofibrate increases MDA level and decreases ATPase activity in pancreatic mitochondrion in obese MSG rats. (A) MDA level, (B) Total ATPase Activity, (C) Na+-K+-ATPase activity and (D) Ca2+-Mg2+-ATPase activity. Nor, normal rats. Con, water treated obese MSG rats. Fen, fenofibrate treated obese MSG rats. Values represented means ± s.e.m. (n = 5-6). *p < 0.05, ***p < 0.001 vs. control.

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us